As a Celgene staff member, you have full access to Datamonitor Healthcare’s wealth of event-sensitive research and analysis, opinion and insight covering major disease areas, drugs, companies and strategic issues shaping the pharma market.
Join your fellow colleagues on January 20th and January 28th to discover how Datamonitor Healthcare can help you gain disease-specific insights, compare products, identify unmet needs and stay aligned with developments critical to your work.
We also offer task-specific training so you can focus on areas of the service that may by of particular interest to you, such as early phase opportunities models, 10-year patient-based forecasts, treatment trends, epidemiology insights, pipeline and marketed drug profiles, company analysis and strategy and market access.
To find out more about training options, please contact James Hornblower:
Cutting-edge data visualizations and interactive dashboards, supported by clear methodologies, will enable you to stay aligned with developments and future trends in oncology, immunology and inflammation, respiratory, cardiovascular, CNS, metabolic and infectious diseases therapies.
Our innovative PharmAspect suite of dashboards enables you to interact with data in new and compelling ways so you can gain valuable insights into your market and drive smarter, more timely decision-making.
PharmAspect comprises six interactive dashboards:
Datamonitor Healthcare’s new China Research and Analysis channel enables you to assess key therapeutic areas impacting China, such as diabetes, and examine patient populations and disease incidence and prevalence estimates over a 15-year period, segmented by China’s city tier system, along with an urban and rural split. Market access data provides practical insights into generics in China as well as key pricing, reimbursement, and regulatory developments so you can understand key trends shaping this complex market and identify potential opportunities for your business.
Expiry View comprises four interactive analytics dashboards that allow you to investigate various aspects of patent expiries and gain valuable insights into biosimilars and generics timings:
The epidemiology interactive analytics dashboards deliver detailed epidemiology forecasts by therapy area, disease and country.
Our newly launched Early Phase Opportunities Models provide interactive 20-year patient-based forecast models with pipeline candidates in phase 1 and phase 2, as well as a new chapter in our pipeline content and SWOT analysis by mechanism of action.
There are six interactive early-phase forecast models, covering asthma, depression, rheumatoid arthritis, hepatitis C, melanoma and non-small cell lung cancer.
Coming soon, our significantly enhanced company analysis resource will provide you with the latest company intelligence, including 10-year company product forecasts and financial and pipeline analysis. Live, Interactive dashboards will enable you to view, switch between, and compare datasets effortlessly, while pipeline data, powered by BioMedTracker, will be updated monthly.
On some occasions, a personal touch can make all the difference.
Our Ask the Analyst service will ensure our team of experts are always on hand to provide additional guidance or bespoke support for issues that are specific to your business. We’ll also collaborate with SCRIP’s team of experienced journalists to create solutions that are best-equipped to meet your requirements.
You now have full access to all articles on our site for the next 28 days.